UP!

AZPN $129.31   View long term graphs

Aspen Technology, Inc. -- known as AspenTech -- is a provider of software and services for the process industries headquartered in Bedford, Massachusetts. AspenTech has 30 offices around the world, on 6 continents.

Founded in 1981, AspenTech was born out a joint research project between the Massachusetts Institute of Technology (MIT) and US Department of Energy—an Advanced System for Process Engineering (ASPEN) Project.

On July 15, 2004, AspenTech was required by the Federal Trade Commission to make divestitures in regard to an anti-trust ruling against its acquisition of HyproTech. This included divestment of batch and continuous simulation systems and integrated engineering software business (AXSYS). In the same year, a class action lawsuit was filed against Aspen Technology and its certain officers over issuance of misleading statements and improper revenue recognition.

On November 24, 2004, the company restated results for the fiscal years ended June 2000 through June 2004 after its audit committee discovered the company improperly accounted for certain software licenses. On March 15, 2005, the company announced that the Audit Committee of the Company's Board of Directors had completed its previously announced financial review and the company had restated its financials for each of the fiscal years ended June 30, 2000 through June 30, 2004.

Aspen Technology was delisted from the NASDAQ on February 19, 2008 for failing to meet financial transparency guidelines of the NASDAQ exchange. In February, 2010 the company was relisted on the NASDAQ exchange.

Under former CEO Mark Fusco, AspenTech executed a corporate turnaround strategy. Examples of steps taken during this period included:

On April 30, 2013, AspenTech announced that Mark Fusco would retire as President & CEO effective September 30, 2013. On October 1, 2013, Antonio Pietri became AspenTech President & CEO.


News

Aspen Technology, Inc. 1.93% (technology)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q2 2021 2021-01-27 Future report Set alerts
Q1 2021 2020-10-28 Future report Set alerts
Q4 2020 2020-08-12 1.54 1.43
Q3 2020 2020-05-06 0.74 0.64
Q2 2020 2020-01-29 0.66 0.56
Q1 2020 2019-10-30 0.79 0.67
Q4 2019 2019-08-07 1.59 1.49
Q3 2019 2019-04-24 0.96 0.88
Q2 2019 2019-01-23 0.92 0.83
Q1 2019 2018-10-24 0.64 0.53

Ratings

2016-06-05 Reiterated Rating KeyBanc Buy $45.00
2016-06-05 Reiterated Rating KeyCorp Buy $45.00
2016-04-29 Initiated Coverage JPMorgan Chase & Co. Underweight $36.00
2016-04-26 Boost Price Target Benchmark Co. Hold $28.00 to $34.00
2016-03-07 Reiterated Rating Canaccord Genuity Hold $33.00
2016-02-17 Reiterated Rating Canaccord Genuity Hold $33.00
2016-02-09 Initiated Coverage Avondale Partners Market Perform $36.00
2016-01-29 Lower Price Target Pacific Crest $50.00 to $45.00
2016-01-29 Lower Price Target Benchmark Co. Hold $34.00 to $28.00
2016-01-29 Lower Price Target Canaccord Genuity Hold $39.00 to $33.00
2016-01-13 Reiterated Rating Canaccord Genuity Hold $39.00
2016-01-13 Downgrade Benchmark Co. Buy to Hold $45.00 to $34.00
2015-10-30 Reiterated Rating Canaccord Genuity Hold $39.00
2015-09-16 Reiterated Rating Pacific Crest Overweight $50.00
2015-09-10 Reiterated Rating William Blair Buy
2015-08-14 Reiterated Rating Canaccord Genuity Hold $39.00
2015-08-14 Lower Price Target Benchmark Co. Buy $45.00
2015-05-15 Upgrade KeyBanc Overweight $50.00
2015-05-04 Reiterated Rating JPMorgan Chase & Co. Underweight $36.00 to $39.00
2015-04-29 Reiterated Rating Canaccord Genuity Buy $37.00 to $39.00
2015-03-19 Initiated Coverage Evercore ISI Buy $45.00
2015-01-22 Downgrade JPMorgan Chase & Co. Neutral to Underweight $46.50 to $36.00
2014-10-29 Downgrade Pacific Crest Outperform to Sector Perform
2014-10-29 Downgrade Canaccord Genuity Buy to Hold $52.00 to $42.00
2014-05-19 Downgrade Summit Research Buy to Hold
2014-04-30 Reiterated Rating JPMorgan Chase & Co. Neutral $46.50
2014-04-30 Upgrade Summit Research Hold to Buy $45.00
2014-01-31 Boost Price Target Benchmark Co. $40.00 to $50.00
2014-01-31 Boost Price Target Pacific Crest $43.00 to $50.00
2014-01-31 Boost Price Target Canaccord Genuity Buy $50.00 to $52.00
2014-01-17 Boost Price Target Canaccord Genuity Buy $42.00 to $50.00
2013-11-19 Downgrade Cross Research Buy to Hold
2013-11-08 Boost Price Target Cowen and Company Outperform $38.00 to $42.00
2013-10-30 Boost Price Target Canaccord Genuity Buy $40.00 to $42.00
2013-10-18 Downgrade JPMorgan Chase & Co. Overweight to Neutral $36.00 to $38.00
2013-10-01 Boost Price Target Benchmark Co. Buy $38.00 to $40.00
2013-08-16 Reiterated The Benchmark Company Buy $35 to $38
2013-05-01 Reiterated The Benchmark Company Buy $33 to $35
2013-01-03 Reiterated The Benchmark Company Buy $27 to $33
2012-08-22 Reiterated The Benchmark Company Buy $25 to $27
2012-04-03 Initiated Brigantine Buy $23
2011-02-17 Initiated Davenport Buy $22
2010-10-04 Initiated William Blair Outperform
2016-06-05 Reiterated Rating KeyBanc Buy $45.00
2016-06-05 Reiterated Rating KeyCorp Buy $45.00
2016-04-29 Initiated Coverage JPMorgan Chase & Co. Underweight $36.00
2016-04-26 Boost Price Target Benchmark Co. Hold $28.00 to $34.00
2016-03-07 Reiterated Rating Canaccord Genuity Hold $33.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Pietri Antonio J EVP, Field Operations 0.26%  (243081) AZPN /
FUSCO MARK President & CEO 0.25%  (225787) AZPN / EXA /
KOTZABASAKIS MANOLIS E EVP, Products 0.07%  (68504) AZPN /
Sullivan Mark P. EVP & CFO 0.06%  (53290) AZPN /
Griffin William EVP, Field Operations 0.05%  (45122) AZPN /
Johnsen Karl E Senior Vice President and CFO 0.04%  (32407) AVID / AZPN /
MCARDLE JOAN C 0.03%  (29792) AZPN / DWCH /
Hammond F G SVP & General Counsel 0.02%  (21568) AZPN /
GANN SIMON OREBI 0.02%  (18300) AZPN /
HAROIAN GARY E 0.01%  (13583) ANET / AZPN / BCOV / ENOC /
Whelan, Jr. Robert M. 0.01%  (11887) ARIA / AZPN /
CASEY DONALD P 0.01%  (6924) AZPN /

Comments